• Profile
Close

Laminin 511 is a target antigen in autoimmune pancreatitis

Science Translational Medicine Aug 18, 2018

Shiokawa M, et al. - In patients with autoimmune pancreatitis (AIP), researchers identified an autoantibody against laminin 511-E8, a truncated laminin 511, one of the extracellular matrix (ECM) proteins. According to the findings obtained, AIP subjects with laminin 511-E8 antibodies showed distinctive clinical features, as the frequencies of malignancies or allergic diseases were significantly lower in patients with laminin 511-E8 antibodies vs those without. The study findings suggested that the discovery of these autoantibodies should help in the understanding of AIP pathophysiology and possibly improve the diagnosis of AIP.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay